GFAP and neurodegenerative disease: For example, the up-regulated levels of neurofilament light chain (NFL) and glial fibrillary acidic protein (GFAP) in serum may indicate neuronal damage in the progression of neurodegenerative diseases, such as Alzheimer’s disease (10) or Parkinson’s disease (11).